169 related articles for article (PubMed ID: 30480430)
1. Phospho-Tau Impairs Nuclear-Cytoplasmic Transport.
Tripathi T; Prakash J; Shav-Tal Y
ACS Chem Neurosci; 2019 Jan; 10(1):36-38. PubMed ID: 30480430
[TBL] [Abstract][Full Text] [Related]
2. Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease.
Eftekharzadeh B; Daigle JG; Kapinos LE; Coyne A; Schiantarelli J; Carlomagno Y; Cook C; Miller SJ; Dujardin S; Amaral AS; Grima JC; Bennett RE; Tepper K; DeTure M; Vanderburg CR; Corjuc BT; DeVos SL; Gonzalez JA; Chew J; Vidensky S; Gage FH; Mertens J; Troncoso J; Mandelkow E; Salvatella X; Lim RYH; Petrucelli L; Wegmann S; Rothstein JD; Hyman BT
Neuron; 2018 Sep; 99(5):925-940.e7. PubMed ID: 30189209
[TBL] [Abstract][Full Text] [Related]
3. Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy.
Cowan CM; Chee F; Shepherd D; Mudher A
Biochem Soc Trans; 2010 Apr; 38(2):564-70. PubMed ID: 20298222
[TBL] [Abstract][Full Text] [Related]
4. Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo.
Violet M; Chauderlier A; Delattre L; Tardivel M; Chouala MS; Sultan A; Marciniak E; Humez S; Binder L; Kayed R; Lefebvre B; Bonnefoy E; Buée L; Galas MC
Neurobiol Dis; 2015 Oct; 82():540-551. PubMed ID: 26385829
[TBL] [Abstract][Full Text] [Related]
5. Abnormal Microtubule Dynamics Impair the Nuclear-Cytoplasmic Transport in Dementia.
Tripathi T; Kalita J
ACS Chem Neurosci; 2019 Mar; 10(3):1133-1134. PubMed ID: 30785261
[TBL] [Abstract][Full Text] [Related]
6. N-terminal truncation of microtubule associated protein tau dysregulates its cellular localization.
Paholikova K; Salingova B; Opattova A; Skrabana R; Majerova P; Zilka N; Kovacech B; Zilkova M; Barath P; Novak M
J Alzheimers Dis; 2015; 43(3):915-26. PubMed ID: 25147106
[TBL] [Abstract][Full Text] [Related]
7. Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?
Alavi Naini SM; Soussi-Yanicostas N
Oxid Med Cell Longev; 2015; 2015():151979. PubMed ID: 26576216
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation but Not Oligomerization Drives the Accumulation of Tau with Nucleoporin Nup98.
Diez L; Kapinos LE; Hochmair J; Huebschmann S; Dominguez-Baquero A; Vogt A; Rankovic M; Zweckstetter M; Lim RYH; Wegmann S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408855
[TBL] [Abstract][Full Text] [Related]
9. Tau phosphorylation and aggregation as a therapeutic target in tauopathies.
Badiola N; Suárez-Calvet M; Lleó A
CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):727-40. PubMed ID: 20942789
[TBL] [Abstract][Full Text] [Related]
10. The Tau of Nuclear-Cytoplasmic Transport.
Lester E; Parker R
Neuron; 2018 Sep; 99(5):869-871. PubMed ID: 30189205
[TBL] [Abstract][Full Text] [Related]
11. Tau-Induced Ca
Wei YP; Ye JW; Wang X; Zhu LP; Hu QH; Wang Q; Ke D; Tian Q; Wang JZ
Neurosci Bull; 2018 Apr; 34(2):261-269. PubMed ID: 28646348
[TBL] [Abstract][Full Text] [Related]
12. Non-Canonical Roles of Tau and Their Contribution to Synaptic Dysfunction.
Siano G; Falcicchia C; Origlia N; Cattaneo A; Di Primio C
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576308
[TBL] [Abstract][Full Text] [Related]
13. Tau hyperphosphorylation affects Smad 2/3 translocation.
Baig S; van Helmond Z; Love S
Neuroscience; 2009 Oct; 163(2):561-70. PubMed ID: 19555739
[TBL] [Abstract][Full Text] [Related]
14. Tauopathies and tau oligomers.
Takashima A
J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
[TBL] [Abstract][Full Text] [Related]
15. Nuclear Pore Dysfunction in Neurodegeneration.
Spead O; Zaepfel BL; Rothstein JD
Neurotherapeutics; 2022 Jul; 19(4):1050-1060. PubMed ID: 36070178
[TBL] [Abstract][Full Text] [Related]
16. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.
Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR
J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568
[TBL] [Abstract][Full Text] [Related]
17. Our Tau Tales from Normal to Pathological Behavior.
Alonso AD; Cohen LS
J Alzheimers Dis; 2018; 64(s1):S507-S516. PubMed ID: 29614672
[TBL] [Abstract][Full Text] [Related]
18. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.
Chiasseu M; Cueva Vargas JL; Destroismaisons L; Vande Velde C; Leclerc N; Di Polo A
J Neurosci; 2016 May; 36(21):5785-98. PubMed ID: 27225768
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies.
Ubhi KK; Shaibah H; Newman TA; Shepherd D; Mudher A
Invert Neurosci; 2007 Sep; 7(3):165-71. PubMed ID: 17636367
[TBL] [Abstract][Full Text] [Related]
20. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
